Navega Therapeutics has developed a patented, non-permanent gene therapy to target pain that is non-addictive, highly specific, and long-lasting. Navega Therapeutics has imitated this process by utilizing a novel gene therapy to target pain in a non-permanent way.

Biotechnology

Navega Therapeutics

Navega Therapeutics' headquarters in San Diego, CA, United States

Ana Moreno

Carol Greve-Philips

Fernando Aleman

Tony L. Yaksh

Mark Wallace

Marcus B. Noyes

Randall E. Woods

Prashant Mali

The leadership team at Navega Therapeutics has a history of research and development in the biomedical engineering industry. They have worked as researchers at the National Institutes of Health, Aztera, The Scripps Research Institute, and University of California, San Diego. They have also been a part of Purdue University, CSIC, and Harvard Medical School as visiting research fellows and postdoctoral associates. The team's education is in bioengineering, business administration, and management from UC San Diego, Harvard Business School, Rady School of Management, and The Johns Hopkins University.

Navega Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Offices

Navega Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Offices

Related companies